NCT01383668View on ClinicalTrials.gov

Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2011

Primary Completion Date

February 8, 2013

Study Completion Date

February 8, 2013

Conditions
Recurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

sirolimus

Given PO

DRUG

gold sodium thiomalate

Given IM

OTHER

pharmacological study

Correlative studies

GENETIC

RNA analysis

Correlative studies

GENETIC

polymerase chain reaction

Correlative studies

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT01383668 - Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter